The virology and clinical effects of peramivir on influenza virus infections in high-risk patients or patients with severe symptoms:an open-label, non-randomized, multi-centre study.
Not Applicable
- Conditions
- Influenza virus infections.
- Registration Number
- JPRN-UMIN000007320
- Lead Sponsor
- Center for Advanced Medical Innovation Kyushu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of hypersensitivity, allergy or serious adverse drug event caused by neuraminidase inhibitors. 2) Pregnant women. 3) Patients who are deemed to be inappropriate by the investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ratio of influenza virus-positive patients.
- Secondary Outcome Measures
Name Time Method Virus mutation after treatment of peramivir. Time to return to normal body temperature. Duration of influenza symptoms.